PM Chung Sye-kyun to make three-day visit to Iran
South Korean Prime Minister Chung Sye-kyun embarks on a three-day trip to Iran today for talks on bilateral issues and other pending matters. He will be meeting with top officials…
Colorectal Cancer: What You Should Know About Screening | FDA News
Image The evidence is clear – screening for colorectal cancer may save your life. Today, more and more people are choosing colorectal cancer screening. As a result, there is a…
S. Korea to resume rollout of AstraZeneca vaccine for people under 60 on Mon. Updated: 2021-04-12 05:47:46 KST
South Korea has decided to resume administering AstraZeneca vaccines to people younger than 60 starting on Monday. The Korea Disease Control and Prevention Agency announced its decision Sunday after discussing…
President Moon welcomes battery dispute settlement between LG and SK Updated: 2021-04-12 11:32:54 KST
President Moon Jae-in has welcomed LG Energy Solution and SK Innovation’s settlement to end their legal dispute. Taking to social media Monday, he said the settlement is meaningful as it…
Seoul willing to support multilateral talks on Iran’s nuclear deal: S. Korean Prime Minister Updated: 2021-04-12 13:11:11 KST
South Korean Prime Minister Chung Sye-kyun, who is on a visit to Iran, says Seoul is willing to support talks among relevant parties regarding the Iran nuclear deal. Prime Minister…
RosewoodTrust Review 2021- Is this award-winning broker worth your investments? (www.rosewoodtrust.com)
In today’s world, with so many options are readily available for online trading and every other trading platform is competing to have the best features they could provide to their…
Gain unfair advantage in Asian market with an Asia newswire service
If you are considering a public relations media strategy for your business in Asia, you need to consider an Asia press release service. Topic News PR is your local PR…
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer | FDA News
For Immediate Release: April 09, 2021 Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine…